subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864

object_name: neoplasm of mediastinum

tested_intervention: unsure


subject: CHEBI:5864

object_name: lymphoblastic lymphoma


subject: CHEBI:5864

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:93775

subject_name: Amethopterin

object_name: mediastinal cancer


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0733688

object_name: Burkitt lymphoma


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: UMLS:C0733688

object_name: acute lymphoblastic leukemia


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: UMLS:C0733688

object_name: Childhood Lymphoblastic Lymphoma


subject: UMLS:C0733688

object_name: anaplastic large cell lymphoma


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:36373

subject_name: vindesine


subject: CHEBI:36373


subject: CHEBI:36373


subject: CHEBI:36373

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:36373


subject: CHEBI:36373


subject: CHEBI:36373


subject: CHEBI:36373


subject: CHEBI:52854

subject_name: gold nanocrystal

object_name: multiple sclerosis

tested_intervention: yes


subject: UMLS:C2980484

subject_name: DaTscan

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:4469988

subject_name: Sabarubicin

object_name: testicular germ cell tumor 1


subject: PUBCHEM.COMPOUND:4469988

object_name: testicular germ cell tumor


subject: PUBCHEM.COMPOUND:4469988

object_name: childhood testicular germ cell tumor


subject: CHEBI:75998

subject_name: Trametinib

object_name: Recurrent Uveal Melanoma


subject: CHEBI:75998

object_name: Stage IV Uveal Melanoma AJCC v7


subject: UNII:ZXM835LQ5E

subject_name: Uprosertib


subject: UNII:ZXM835LQ5E


subject: MESH:D049971

subject_name: Thiazides

object_name: essential hypertension


subject: CHEBI:50264

subject_name: thiazide


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: chronic pancreatitis


subject: MESH:D000077325

object_name: hereditary chronic pancreatitis


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Myelodysplasia


subject: CHEBI:74947

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:74947

object_name: childhood myelodysplastic syndrome


subject: CHEBI:74947

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:8382

subject_name: Prednisone

object_name: congestive heart failure


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: ERBB2 Exon 20 Mutation


subject: CHEBI:231178

object_name: Neck Carcinoma


subject: CHEBI:231178

object_name: head and neck neoplasm


subject: CHEBI:231178

object_name: head and neck cancer


subject: UMLS:C0907160

subject_name: Pegylated Interferon Alfa

object_name: Liver Fibrosis


subject: CHEBI:6538

subject_name: Loratadine

object_name: urticaria


subject: CHEBI:6538

object_name: reported urticaria (physical finding)


subject: CHEBI:6538

object_name: Urticaria, CTCAE


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: periodontal disorder


subject: CHEBI:31683

subject_name: I-123 BMIPP

object_name: acute coronary syndrome


subject: UMLS:C4727207

subject_name: Nidanilimab

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:63724


subject: UNII:YB18NF020M

subject_name: Satralizumab

object_name: facioscapulohumeral muscular dystrophy 1


subject: UNII:UG97LO5M8Y

subject_name: Tesetaxel

object_name: prostate carcinoma


subject: UNII:UG97LO5M8Y

object_name: prostate cancer


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: heart failure


subject: CHEBI:73604

object_name: Heart Failure, CTCAE


subject: UNII:D7NM51C3GU

object_name: Refractory infantile spasms


subject: UNII:KV1M7Q3CBP

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:74947

object_name: diffuse large B-cell lymphoma


subject: CHEBI:59527

object_name: Alzheimer disease type 1


subject: CHEBI:59527

object_name: Alzheimer disease


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: MESH:C097921

object_name: endometrial clear cell adenocarcinoma


subject: MESH:C097921

object_name: endometrial serous adenocarcinoma


subject: MESH:C097921

object_name: Stage I Endometrial Carcinoma


subject: MESH:C097921

object_name: Endometrial cancer stage III


subject: MESH:C097921

object_name: Endometrial cancer stage II


subject: MESH:C097921

object_name: Cervical carcinoma stage IIA


subject: MESH:C097921

object_name: Stage IIA Cervical Cancer AJCC v6


subject: MESH:C097921

object_name: Stage IIA Cervical Cancer AJCC v8


subject: MESH:C097921

object_name: Stage IIA Cervical Cancer AJCC v7


subject: MESH:C097921

object_name: stage III cervical cancer


subject: MESH:C097921

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: MESH:C097921

object_name: Stage III Cervical Cancer AJCC v8


subject: MESH:C097921

object_name: Stage IB Cervical Cancer AJCC v8


subject: MESH:C097921

object_name: stage IB cervical cancer


subject: MESH:C097921

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: MESH:C097921

object_name: cervical small cell carcinoma


subject: MESH:C097921

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: MESH:C097921

object_name: Cervical carcinoma stage IIB


subject: MESH:C097921

object_name: Stage IIB Cervical Cancer AJCC v8


subject: MESH:C097921

object_name: Stage IVA Cervical Cancer AJCC v8


subject: MESH:C097921

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: MESH:C097921

object_name: Cervical carcinoma stage IVA


subject: MESH:C097921

object_name: cervical squamous cell carcinoma


subject: MESH:C097921

object_name: cervical adenocarcinoma


subject: MESH:C097921

object_name: cervical adenosquamous carcinoma


subject: CHEBI:50819

subject_name: Ferric oxide

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:50819

object_name: endometrial serous adenocarcinoma


subject: CHEBI:50819

object_name: Stage I Endometrial Carcinoma


subject: CHEBI:50819

object_name: Endometrial cancer stage III


subject: CHEBI:50819

object_name: Endometrial cancer stage II


subject: CHEBI:50819

object_name: Cervical carcinoma stage IIA


subject: CHEBI:50819

object_name: Stage IIA Cervical Cancer AJCC v6


subject: CHEBI:50819

object_name: Stage IIA Cervical Cancer AJCC v8


subject: CHEBI:50819

object_name: Stage IIA Cervical Cancer AJCC v7


subject: CHEBI:50819

object_name: stage III cervical cancer


subject: CHEBI:50819

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: CHEBI:50819

object_name: Stage III Cervical Cancer AJCC v8


subject: CHEBI:50819

object_name: Stage IB Cervical Cancer AJCC v8


subject: CHEBI:50819

object_name: stage IB cervical cancer


subject: CHEBI:50819

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: CHEBI:50819

object_name: cervical small cell carcinoma


subject: CHEBI:50819

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: CHEBI:50819

object_name: Cervical carcinoma stage IIB


subject: CHEBI:50819

object_name: Stage IIB Cervical Cancer AJCC v8


subject: CHEBI:50819

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:50819

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:50819

object_name: Cervical carcinoma stage IVA


subject: CHEBI:50819

object_name: cervical squamous cell carcinoma


subject: CHEBI:50819

object_name: cervical adenocarcinoma


subject: CHEBI:50819

object_name: cervical adenosquamous carcinoma


subject: PUBCHEM.COMPOUND:101882900

subject_name: NIZUBAGLUSTAT

object_name: Niemann-Pick disease type C


subject: UNII:2X6NHN9RRN


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: end stage renal failure


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0812735

object_name: mantle cell lymphoma


subject: UMLS:C0812735

object_name: diffuse large B-cell lymphoma


subject: UMLS:C0812735

object_name: marginal zone lymphoma


subject: UMLS:C0812735

object_name: MALT lymphoma


subject: UMLS:C0812735

object_name: mediastinal malignant lymphoma


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772


subject: CHEBI:7772


subject: CHEBI:7772


subject: CHEBI:7772


subject: CHEBI:7772


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:8805

subject_name: Repaglinide


subject: CHEBI:8805


subject: CHEBI:8805


subject: CHEBI:8805


subject: CHEBI:8805


subject: CHEBI:8805


subject: CHEBI:231598

subject_name: Tazemetostat


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: UMLS:C0920330

subject_name: Pancreatic enzyme

object_name: short bowel syndrome


subject: CHEBI:6931

subject_name: Midazolam

object_name: Dyssomnias


subject: CHEBI:6931

object_name: Sleep abnormality


subject: CHEBI:6931

object_name: Post-Operative Pain


subject: CHEBI:6931

object_name: sleep disorder


subject: CHEBI:125427

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:125427


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: Rett syndrome


subject: CHEBI:16919

subject_name: Creatine


subject: UMLS:C4043330

object_name: multiple sclerosis


subject: UMLS:C1321801

subject_name: Fiber brand of calcium polycarbophil

object_name: Heart Disease Risk Factors


subject: UMLS:C0225326

subject_name: fiber


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: amyloidosis


subject: CHEBI:15365

subject_name: Aspirin

object_name: hyperlipidemia


subject: CHEBI:15365

object_name: hyperlipoproteinemia


subject: CHEBI:15365

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:15365

object_name: Serum lipids high (finding)


subject: UMLS:C2826383

object_name: renal cell carcinoma


subject: UMLS:C2826383

object_name: kidney disorder


subject: UMLS:C2826383

object_name: kidney neoplasm


subject: UMLS:C2826383

object_name: kidney cancer


subject: CHEBI:94782

subject_name: Cediranib

object_name: endometrium neoplasm


subject: CHEBI:94782

object_name: carcinosarcoma


subject: CHEBI:83766

subject_name: Olaparib


subject: PUBCHEM.COMPOUND:24181126

subject_name: Fluorescite

object_name: ventricular septal defect


subject: PUBCHEM.COMPOUND:24181126

object_name: Tetralogy of Fallot with pulmonary stenosis


subject: PUBCHEM.COMPOUND:24181126

object_name: Atrioventricular septal defect: atrial and ventricular components


subject: PUBCHEM.COMPOUND:24181126

object_name: complete atrioventricular canal


subject: CHEBI:172923

subject_name: FLUORESCEIN


subject: CHEBI:172923


subject: CHEBI:172923


subject: CHEBI:172923


subject: UMLS:C0720479


subject: UMLS:C0720479


subject: UMLS:C0720479


subject: UMLS:C0720479


subject: PUBCHEM.COMPOUND:9834332

subject_name: Brivaracetam

object_name: mild neurocognitive disorder


subject: PUBCHEM.COMPOUND:9834332

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:9834332

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:9834332

object_name: Alzheimer disease


subject: UniProtKB:P20334-1

subject_name: tumor necrosis factor receptor superfamily member 9 isoform 1 (mouse)

object_name: melanoma


subject: UMLS:C1831875

subject_name: urelumab


subject: PUBCHEM.COMPOUND:157088853

subject_name: Reamberin

object_name: metabolic acidosis


subject: UMLS:C2933941

subject_name: meglumine sodium succinate


subject: CHEBI:7772

subject_name: omeprazole

object_name: duodenal ulcer


subject: CHEBI:7772

object_name: Duodenal Ulcer, CTCAE


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: CHEBI:51254


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Atrophy of alveolar ridges


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: morbid obesity


subject: CHEBI:194186

object_name: Class 3 Obesity


subject: UNII:MQ908Y1ZB2

object_name: diabetic neuropathy


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: chronic pain syndrome


subject: UMLS:C0678449

object_name: chronic pain due to trauma


subject: UMLS:C0678449

object_name: Chronic pain due to injury


subject: UMLS:C0678449

object_name: Chronic Traumatic Encephalopathy


subject: UMLS:C0678449

object_name: dementia pugilistica


subject: UMLS:C0678449

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C0678449

object_name: amyotrophic lateral sclerosis


subject: UMLS:C0678449

object_name: inflammatory bowel disease


subject: UMLS:C0678449

object_name: multiple sclerosis


subject: UMLS:C0678449

object_name: Coronavinae infectious disease


subject: UMLS:C0678449

object_name: traumatic encephalopathy


subject: UMLS:C0678449

object_name: traumatic brain injury


subject: UMLS:C0678449

object_name: ulcerative colitis


subject: UMLS:C0678449

object_name: inflammatory bowel disease 1


subject: UMLS:C0678449

object_name: severe acute respiratory syndrome


subject: UMLS:C0678449

object_name: sickle cell disease


subject: UMLS:C0678449

object_name: opiate dependence


subject: UMLS:C0678449

object_name: Parkinson disease


subject: UMLS:C0678449

object_name: bipolar disorder


subject: UMLS:C0678449

object_name: Crohn disease


subject: UMLS:C0678449

object_name: fibromyalgia


subject: UMLS:C0678449

object_name: hepatitis C


subject: UMLS:C0678449

object_name: insomnia


subject: UMLS:C0678449

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C0678449

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C0678449

object_name: Seizure Related to COVID-19


subject: UMLS:C0678449

object_name: epilepsy


subject: UMLS:C0678449

object_name: visual epilepsy


subject: UMLS:C0678449

object_name: glaucoma


subject: UMLS:C0678449

object_name: Glaucoma, CTCAE


subject: UMLS:C0678449

object_name: AIDS


subject: UMLS:C0678449

object_name: pervasive developmental disorder


subject: UMLS:C0678449

object_name: autism


subject: UMLS:C0678449

object_name: cancer


subject: UMLS:C0678449

object_name: neoplasm


subject: UMLS:C0678449


subject: UMLS:C0024808

subject_name: Marihuana

object_name: chronic pain syndrome


subject: UMLS:C0024808

object_name: chronic pain due to trauma


subject: UMLS:C0024808

object_name: Chronic pain due to injury


subject: UMLS:C0024808

object_name: Chronic Traumatic Encephalopathy


subject: UMLS:C0024808

object_name: dementia pugilistica


subject: UMLS:C0024808

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C0024808

object_name: amyotrophic lateral sclerosis


subject: UMLS:C0024808

object_name: inflammatory bowel disease


subject: UMLS:C0024808

object_name: multiple sclerosis


subject: UMLS:C0024808

object_name: Coronavinae infectious disease


subject: UMLS:C0024808

object_name: traumatic encephalopathy


subject: UMLS:C0024808

object_name: traumatic brain injury


subject: UMLS:C0024808

object_name: ulcerative colitis


subject: UMLS:C0024808

object_name: inflammatory bowel disease 1


subject: UMLS:C0024808

object_name: severe acute respiratory syndrome


subject: UMLS:C0024808

object_name: sickle cell disease


subject: UMLS:C0024808

object_name: opiate dependence


subject: UMLS:C0024808

object_name: Parkinson disease


subject: UMLS:C0024808

object_name: bipolar disorder


subject: UMLS:C0024808

object_name: Crohn disease


subject: UMLS:C0024808

object_name: fibromyalgia


subject: UMLS:C0024808

object_name: hepatitis C


subject: UMLS:C0024808

object_name: insomnia


subject: UMLS:C0024808

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C0024808

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C0024808

object_name: Seizure Related to COVID-19


subject: UMLS:C0024808

object_name: epilepsy


subject: UMLS:C0024808

object_name: visual epilepsy


subject: UMLS:C0024808

object_name: glaucoma


subject: UMLS:C0024808

object_name: Glaucoma, CTCAE


subject: UMLS:C0024808

object_name: AIDS


subject: UMLS:C0024808

object_name: pervasive developmental disorder


subject: UMLS:C0024808

object_name: autism


subject: UMLS:C0024808

object_name: cancer


subject: UMLS:C0024808

object_name: neoplasm


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract

object_name: chronic pain syndrome


subject: UMLS:C4552088

object_name: chronic pain due to trauma


subject: UMLS:C4552088

object_name: Chronic pain due to injury


subject: UMLS:C4552088

object_name: Chronic Traumatic Encephalopathy


subject: UMLS:C4552088

object_name: dementia pugilistica


subject: UMLS:C4552088

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C4552088

object_name: amyotrophic lateral sclerosis


subject: UMLS:C4552088

object_name: inflammatory bowel disease


subject: UMLS:C4552088

object_name: multiple sclerosis


subject: UMLS:C4552088

object_name: Coronavinae infectious disease


subject: UMLS:C4552088

object_name: traumatic encephalopathy


subject: UMLS:C4552088

object_name: traumatic brain injury


subject: UMLS:C4552088

object_name: ulcerative colitis


subject: UMLS:C4552088

object_name: inflammatory bowel disease 1


subject: UMLS:C4552088

object_name: severe acute respiratory syndrome


subject: UMLS:C4552088

object_name: sickle cell disease


subject: UMLS:C4552088

object_name: opiate dependence


subject: UMLS:C4552088

object_name: Parkinson disease


subject: UMLS:C4552088

object_name: bipolar disorder


subject: UMLS:C4552088

object_name: Crohn disease


subject: UMLS:C4552088

object_name: fibromyalgia


subject: UMLS:C4552088

object_name: hepatitis C


subject: UMLS:C4552088

object_name: insomnia


subject: UMLS:C4552088

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C4552088

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C4552088

object_name: Seizure Related to COVID-19


subject: UMLS:C4552088

object_name: epilepsy


subject: UMLS:C4552088

object_name: visual epilepsy


subject: UMLS:C4552088

object_name: glaucoma


subject: UMLS:C4552088

object_name: Glaucoma, CTCAE


subject: UMLS:C4552088

object_name: AIDS


subject: UMLS:C4552088

object_name: pervasive developmental disorder


subject: UMLS:C4552088

object_name: autism


subject: UMLS:C4552088

object_name: cancer


subject: UMLS:C4552088

object_name: neoplasm


subject: UMLS:C4552088


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: Hepatic impairment


subject: UMLS:C5206405

subject_name: Microbial Ecosystem Therapeutics-4

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C5691056

object_name: focal segmental glomerulosclerosis


subject: CHEBI:50848

subject_name: Loteprednol

object_name: choroidal neovascularization (physical finding)


subject: CHEBI:50848

object_name: diabetic retinopathy


subject: CHEBI:50848

object_name: Macular Edema


subject: CHEBI:50848

object_name: Venous occlusion


subject: CHEBI:31401

subject_name: Cilostazol

object_name: Arterial stenosis


subject: PUBCHEM.COMPOUND:541197

subject_name: Norethindrone acetate

object_name: Endometrioma


subject: CHEBI:7627

subject_name: Norethisterone


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:91951

object_name: Hormone Receptor Positive


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:8249

subject_name: Piroxicam

object_name: epicondylitis


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:64064

subject_name: Salmeterol

object_name: chronic bronchitis


subject: CHEBI:64064

object_name: bronchitis


subject: CHEBI:64064

object_name: emphysema


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:5134


subject: CHEBI:5134


subject: UMLS:C2267009

subject_name: Androgen Receptor Inhibitor [EPC]

object_name: prostate carcinoma


subject: UMLS:C2267009

object_name: prostate cancer


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid

object_name: Growth delay


subject: UNII:C9H2L21V7U

object_name: Failure to Thrive


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Complications of transplanted organs and tissue


subject: CHEBI:201431

object_name: DIABETES MELLITUS NOS NEW ONSET


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: hepatitis B


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: CHEBI:84040


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Ambulatory Status - Mastectomy


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Acute low back pain


subject: UMLS:C5442122

subject_name: VITAMIN B


subject: UMLS:C1704763

subject_name: B Vitamin Family


subject: CHEBI:75769

subject_name: B vitamin


subject: CHEMBL.COMPOUND:CHEMBL2108015

subject_name: VITAMIN B COMPLEX


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: Wound healed (finding)


subject: CHEBI:34385

object_name: Traumatic Wound


subject: CHEBI:34385

object_name: Wounds and Injuries


subject: CHEBI:34385

object_name: Cutaneous wound


subject: CHEBI:35530

subject_name: beta-adrenergic antagonist

object_name: atrial fibrillation


subject: CHEBI:35530

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:35530

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:35530

object_name: Heart failure with normal ejection fraction


subject: CHEBI:35530

object_name: Diastolic dysfunction


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists


subject: PUBCHEM.COMPOUND:6420057

subject_name: METOPROLOL TARTRATE


subject: PUBCHEM.COMPOUND:6420057


subject: PUBCHEM.COMPOUND:6420057


subject: PUBCHEM.COMPOUND:6420057


subject: PUBCHEM.COMPOUND:6420057


subject: CHEBI:6904

subject_name: Metoprolol


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE


subject: PUBCHEM.COMPOUND:9800288


subject: PUBCHEM.COMPOUND:9800288


subject: PUBCHEM.COMPOUND:9800288


subject: CHEBI:169833

subject_name: Deacetyldiltiazem


subject: CHEBI:169833


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:82814


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:101278


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Malignant neoplasm of female breast


subject: UMLS:C1527137

object_name: female breast carcinoma


subject: CHEBI:59527

object_name: Hemorrhage


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: DRUGBANK:DB15656

subject_name: ChAdOx1 nCoV-19

object_name: Vaccine adverse reaction


subject: DRUGBANK:DB15656

object_name: Vaccine-Preventable Diseases


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran


subject: UMLS:C5575181

subject_name: Janssen COVID-19 Vaccine


subject: PUBCHEM.COMPOUND:53716604

subject_name: Fluorodeoxyglucose

object_name: sarcoidosis


subject: PUBCHEM.COMPOUND:53716604

object_name: sarcoidosis, susceptibility to, 1


subject: UMLS:C4553797


subject: UMLS:C4553797


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:49847


subject: CHEBI:49847


subject: CHEBI:33322

subject_name: Rubidium


subject: CHEBI:33322


subject: CHEBI:3561

subject_name: Cetirizine

object_name: History of allergies


subject: CHEBI:229722

subject_name: camonsertib

object_name: Advanced cancer


subject: UMLS:C5418075

subject_name: ATR Inhibitor RP-3500


subject: UMLS:C5555610

subject_name: PKMYT1 Inhibitor RP-6306


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Lymphoma, Large-Cell, Follicular


subject: CHEBI:173077


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Stage 4 chronic kidney disease


subject: CHEBI:81579

object_name: Stage 3 chronic kidney disease


subject: UMLS:C0677807

subject_name: Aminocamptothecin Colloidal Dispersion

object_name: renal carcinoma


subject: UMLS:C0677807

object_name: kidney neoplasm


subject: UMLS:C0677807

object_name: kidney cancer


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Equinus Deformity


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: Clostridium difficile colitis


subject: CHEBI:3223

subject_name: Buspirone

object_name: systemic sclerosis


subject: CHEBI:8871

subject_name: Risperidone


subject: UNII:DQP38C562S

object_name: pain agnosia


subject: UNII:DQP38C562S

object_name: Pain insensitivity


subject: UMLS:C5853783


subject: UMLS:C5853783


subject: CHEBI:82960

subject_name: Raltegravir

object_name: HIV-associated neurocognitive disorder


subject: CHEBI:82960

object_name: neurotoxicity


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: diabetic kidney disease


subject: CHEBI:23965

subject_name: estradiol

object_name: type 2 diabetes mellitus


subject: CHEBI:23965

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Failure of osseointegration of dental implant


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:18258

subject_name: Liothyronine

object_name: congenital heart disease


subject: CHEMBL.COMPOUND:CHEMBL3989992

subject_name: PEGILODECAKIN

object_name: non-small cell lung carcinoma


subject: CHEBI:125427

object_name: X-linked dominant hypophosphatemic rickets


subject: CHEBI:125427

object_name: X-linked hypophosphatemic rickets


subject: CHEBI:125427

object_name: vitamin D-dependent rickets, type 2


subject: CHEBI:125427

object_name: hypophosphatemic rickets


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: UMLS:C5392518

object_name: fibrosis


subject: UMLS:C0796512

subject_name: CCI 779

object_name: rheumatoid arthritis


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Coronavinae infectious disease


subject: CHEBI:47657

subject_name: Roflumilast

object_name: mild neurocognitive disorder


subject: CHEBI:47657

object_name: mild cognitive impairment


subject: CHEBI:47657

object_name: Mild dementia


subject: CHEBI:47657

object_name: Amnestic mild cognitive disorder


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:90863

subject_name: Sonidegib


subject: UMLS:C1879683

subject_name: Hyperacute Lung Cancer Vaccine


subject: CHEBI:5613

subject_name: Haloperidol

object_name: Postoperative confusion


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Childhood Breast Carcinoma


subject: CHEBI:61080

object_name: breast carcinoma


subject: CHEBI:61080

object_name: breast cancer


subject: CHEBI:61080

object_name: triple-negative breast carcinoma


subject: CHEBI:61080

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:67272

subject_name: Perifosine

object_name: cancer


subject: CHEBI:18332

subject_name: Levothyroxine

object_name: autoimmune thyroid disease


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Analgesic effect


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Cushing syndrome


subject: UNII:MRL3739G66

object_name: hyperaldosteronism


subject: UNII:Y68179SY2L


subject: UNII:Y68179SY2L


subject: CHEBI:143658

object_name: adrenal cortex carcinoma


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Shoulder pain


subject: CHEBI:41879

object_name: Shoulder Injuries


subject: CHEBI:41879

object_name: Disorder of shoulder


subject: CHEBI:41879

object_name: Disorder of tendon of biceps


subject: CHEBI:41879

object_name: Disorder of rotator cuff


subject: PUBCHEM.COMPOUND:71487030

subject_name: proximod

object_name: rheumatoid arthritis


subject: CHEBI:85164

subject_name: Nintedanib

object_name: Drug Interactions


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Deep Venous Thrombosis Related to COVID-19


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: skin neoplasm


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:8107

subject_name: Phenytoin

object_name: Seizure Related to COVID-19


subject: CHEBI:8107

object_name: visual epilepsy


subject: CHEBI:8107

object_name: pneumococcal meningitis


subject: PUBCHEM.COMPOUND:75038

object_name: Vascular Stiffness


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:55379

subject_name: camphorsulfonic acid

object_name: adult lymphoma


subject: CHEBI:55379

object_name: lymphoma


subject: CHEBI:55379

object_name: pediatric lymphoma


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: PR:000007170


subject: PR:000007170


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: UniProtKB:P47802


subject: UniProtKB:P47802


subject: PR:000010755


subject: PR:000010755


subject: PR:000010755


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: anxiety


subject: CHEBI:53760

object_name: anxiety disorder


subject: CHEBI:53760

object_name: Anxiety symptoms


subject: CHEBI:53760

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:53760

object_name: Anxiety, CTCAE 5.0


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: Postoperative ileus


subject: PUBCHEM.COMPOUND:20594489

subject_name: Bremelanotide

object_name: kidney disorder


subject: PUBCHEM.COMPOUND:20594489

object_name: impaired renal function disease


subject: UMLS:C1311125


subject: UMLS:C1311125


subject: UMLS:C5235872

subject_name: CDK1 Inhibitor BEY1107

object_name: metastatic colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL5095370

subject_name: TULISOKIBART

object_name: ulcerative colitis


subject: CHEMBL.COMPOUND:CHEMBL5095370

object_name: inflammatory bowel disease 1


subject: CHEMBL.COMPOUND:CHEMBL5095370

object_name: Crohn disease


subject: UMLS:C5783740

subject_name: Tulisokibart


subject: UMLS:C5783740


subject: UMLS:C5783740


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Bedwetting


subject: CHEBI:3699

subject_name: Cimetidine

object_name: endometrial cancer


subject: CHEBI:3699

object_name: uterine corpus cancer


subject: CHEBI:3699

object_name: endometrial carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: UNII:QP166M390Q

subject_name: Ataciguat

object_name: Moderate aortic valve stenosis


subject: CHEBI:15365

subject_name: Aspirin

object_name: acute respiratory distress syndrome


subject: CHEBI:15365

object_name: adult acute respiratory distress syndrome


subject: CHEMBL.COMPOUND:CHEMBL5095277

subject_name: G17DT IMMUNOGEN

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5095277

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095277

object_name: malignant pancreatic neoplasm


subject: UNII:A7YG62NHZ6

subject_name: VUPANORSEN

object_name: Dyslipidemia


subject: UNII:A7YG62NHZ6

object_name: hyperlipidemia


subject: UNII:A7YG62NHZ6

object_name: hyperlipoproteinemia


subject: UNII:U946SH95EE

subject_name: Milk thistle

object_name: body dysmorphic disorder


subject: UMLS:C0872906

subject_name: milk thistle seed extract


subject: CHEBI:177298

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:177298

object_name: Ovarian cancer stage IV


subject: CHEBI:177298

object_name: Ovarian cancer stage III


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: UNII:CMJ4GT6MRD

object_name: schizophrenia


subject: CHEBI:78543

subject_name: Ponatinib

object_name: glioblastoma


subject: CHEBI:78543

object_name: Childhood Glioblastoma


subject: CHEBI:78543

object_name: adult glioblastoma


subject: UMLS:C4521070

object_name: Dyspepsia, CTCAE


subject: UMLS:C2718754

subject_name: Ilaris

object_name: Primary gout


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: stage IB non-small cell lung cancer


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Non-small cell lung cancer stage II


subject: UNII:D99YVK4L0X

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: heart disorder


subject: CHEBI:5001

object_name: HIV infection


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940

object_name: Insulin resistance


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: pleural mesothelioma


subject: UNII:28X28X9OKV

object_name: malignant pleural mesothelioma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:3YEA04NV6H

subject_name: Silatecan

object_name: Adult Gliosarcoma


subject: UNII:3YEA04NV6H

object_name: gliosarcoma


subject: UNII:3YEA04NV6H

object_name: Childhood Gliosarcoma


subject: UNII:3YEA04NV6H


subject: UNII:3YEA04NV6H

object_name: Brain Stem Glioblastoma


subject: UNII:3YEA04NV6H

object_name: glioma susceptibility 1


subject: UMLS:C0961890


subject: UMLS:C0961890


subject: UMLS:C0961890


subject: UMLS:C0961890

object_name: glioblastoma


subject: UMLS:C0961890


subject: UMLS:C0961890


subject: UMLS:C5418059

subject_name: AMG 191

object_name: Myelodysplasia


subject: UMLS:C5418059

object_name: adult acute myeloid leukemia


subject: UMLS:C5418059

object_name: Leukemia - acute myeloid leukemia (AML)


subject: UMLS:C5418059

object_name: childhood acute myeloid leukemia


subject: UMLS:C5418059

object_name: acute myeloid leukemia


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: Well male adult


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: asthma


subject: CHEBI:31300

subject_name: BOSENTAN


subject: CHEBI:51450

subject_name: Bosentan


subject: UNII:1B8447E7YI

subject_name: CLOMIPHENE CITRATE

object_name: acromegaly


subject: UNII:1B8447E7YI

object_name: Acral overgrowth


subject: CHEBI:3752

subject_name: Clomifene


subject: CHEBI:3752


subject: CHEBI:201450

subject_name: Icotinib hydrochloride

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C3274573

subject_name: Icotinib Hydrochloride


subject: PR:000004692

subject_name: Bcl-2-related protein A1

object_name: ovarian cancer


subject: PR:000004692

object_name: ovarian neoplasm


subject: PR:000004692

object_name: ovarian carcinoma


subject: PR:000004692

object_name: cancer


subject: PR:000004692

object_name: neoplasm


subject: PR:000004692

object_name: fallopian tube carcinoma


subject: PR:000004692

object_name: fallopian tube cancer


subject: PR:000004692

object_name: Solid Neoplasm


subject: PR:000004692

object_name: Embolism, Tumor


subject: PR:000004692

object_name: Neoplasm Metastasis


subject: PR:000004692

object_name: Metastatic Lesion


subject: PR:000004692

object_name: carcinoma


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: UMLS:C1521896

subject_name: Monoclonal Antibody B3


subject: UMLS:C1521896


subject: UMLS:C1521896


subject: UMLS:C1521896


subject: UMLS:C1521896


subject: UMLS:C1521896


subject: UMLS:C1521896


subject: UMLS:C1521896


subject: UMLS:C1521896


subject: UMLS:C1521896


subject: UMLS:C1521896


subject: UMLS:C1521896


subject: CHEBI:166975

subject_name: soybean oil

object_name: total parenteral nutrition


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Unresectable Digestive System Neuroendocrine Tumor G2


subject: UNII:MRL3739G66

object_name: Unresectable Digestive System Neuroendocrine Tumor G1


subject: UNII:MRL3739G66

object_name: Metastatic Digestive System Neuroendocrine Tumor G2


subject: UNII:MRL3739G66

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: kidney failure


subject: UMLS:C2608320

subject_name: Aspirin Low Dose

object_name: Ischemic stroke


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: PUBCHEM.COMPOUND:435949

object_name: non-Hodgkin lymphoma


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:167661

object_name: leukemia


subject: CHEBI:167661

object_name: childhood leukemia


subject: CHEBI:77733

subject_name: Verapamil

object_name: Cerebral Vasospasm


subject: CHEBI:28787

subject_name: Nitroglycerin


subject: UMLS:C1660057

subject_name: nicotinamide topical

object_name: actinic keratosis


subject: PUBCHEM.COMPOUND:578771

subject_name: Betamethasone 17 Valerate

object_name: psoriasis


subject: CHEBI:32184

subject_name: Tazarotene


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: migraine


subject: PUBCHEM.COMPOUND:435949

object_name: Vascular calcification


subject: CHEBI:74327


subject: CHEBI:32150


subject: CHEBI:132112


subject: UNII:97IQ273H4L

subject_name: Fostemsavir

object_name: HIV infection


subject: CHEBI:134689

subject_name: Rucaparib

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Inflammation


subject: CHEBI:30314

object_name: malnutrition


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:17460


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: UMLS:C4053683

subject_name: ADC ADCT-301

object_name: triple-negative breast carcinoma


subject: UMLS:C4053683

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4053683

object_name: non-small cell lung carcinoma


subject: UMLS:C4053683

object_name: fallopian tube carcinoma


subject: UMLS:C4053683

object_name: fallopian tube cancer


subject: UMLS:C4053683

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4053683

object_name: clear cell renal carcinoma


subject: UMLS:C4053683

object_name: renal cell adenocarcinoma


subject: UMLS:C4053683

object_name: renal cell carcinoma


subject: UMLS:C4053683

object_name: colorectal carcinoma


subject: UMLS:C4053683

object_name: carcinoma of esophagus


subject: UMLS:C4053683

object_name: esophageal cancer


subject: UMLS:C4053683

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4053683

object_name: neoplasm of esophagus


subject: UMLS:C4053683

object_name: pancreatic neoplasm


subject: UMLS:C4053683

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4053683

object_name: malignant pancreatic neoplasm


subject: UMLS:C4053683

object_name: bladder tumor


subject: UMLS:C4053683

object_name: urinary bladder carcinoma


subject: UMLS:C4053683

object_name: urinary bladder cancer


subject: UMLS:C4053683

object_name: childhood bladder carcinoma


subject: UMLS:C4053683

object_name: ovarian cancer


subject: UMLS:C4053683

object_name: ovarian neoplasm


subject: UMLS:C4053683

object_name: ovarian carcinoma


subject: UMLS:C4053683

object_name: Stomach cancer


subject: UMLS:C4053683

object_name: gastric cancer


subject: UMLS:C4053683

object_name: melanoma


subject: CHEMBL.COMPOUND:CHEMBL1201315

subject_name: TECHNETIUM

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1201315

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1201315

object_name: breast cancer


subject: UMLS:C1337333

subject_name: SESTAMIBI


subject: UMLS:C1337333


subject: UMLS:C1337333


subject: UNII:971Z4W1S09

subject_name: Technetium Tc-99m sestamibi


subject: UNII:971Z4W1S09


subject: UNII:971Z4W1S09


subject: CHEBI:66910

subject_name: Axitinib

object_name: hepatobiliary neoplasm


subject: CHEBI:66910

object_name: biliary tract neoplasm


subject: CHEBI:66910

object_name: liver neoplasm


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: PUBCHEM.COMPOUND:71300755

subject_name: Serelaxin

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:71300755

object_name: coronary atherosclerosis


subject: UNII:W0122B976Y

subject_name: SERELAXIN


subject: UNII:W0122B976Y


subject: DRUGBANK:DB15854

object_name: Breakthrough Infections


subject: MESH:D000090983

subject_name: 2019-nCoV Vaccine mRNA-1273


subject: PUBCHEM.COMPOUND:16143379

subject_name: Human epidermal growth factor

object_name: Diabetic foot ulcer


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: migraine


subject: CHEBI:51230

object_name: headache disorder


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Unresectable Biliary Tract Carcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Parosmia


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:232556

subject_name: Erdafitinib

object_name: lung cancer


subject: CHEBI:232556

object_name: lung neoplasm


subject: CHEBI:232556

object_name: non-small cell lung carcinoma


subject: CHEBI:232556

object_name: squamous cell lung carcinoma


subject: CHEBI:232556

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:42797

subject_name: Gabapentin

object_name: sickle cell disease


subject: CHEBI:9168

subject_name: Sirolimus

object_name: mild cognitive impairment


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor

object_name: premature ejaculation


subject: UMLS:C0162758

subject_name: Serotonin Uptake Inhibitors


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: CHEBI:32184

subject_name: Tazarotene

object_name: Psoriasis of scalp


subject: CHEBI:233309

subject_name: Adagrasib

object_name: Well adult


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag


subject: PUBCHEM.COMPOUND:46874763

object_name: Chest--Diseases


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C4725080

object_name: Alzheimer disease type 1


subject: UMLS:C4725080

object_name: Alzheimer disease


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: periodontitis, chronic, adult


subject: UNII:T42P99266K

object_name: chronic periodontitis


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Adult Grade I Meningioma


subject: UNII:2S9ZZM9Q9V

object_name: adult meningeal hemangiopericytoma


subject: UNII:2S9ZZM9Q9V

object_name: neurofibromatosis


subject: UNII:2S9ZZM9Q9V

object_name: NF2-related schwannomatosis


subject: UNII:2S9ZZM9Q9V

object_name: vestibular schwannomatosis


subject: UNII:2S9ZZM9Q9V

object_name: neurofibromatosis 1


subject: UNII:2S9ZZM9Q9V

object_name: neurofibromatosis type 1


subject: UNII:2S9ZZM9Q9V

object_name: acoustic neuroma


subject: UNII:OS7097575K

subject_name: Parsaclisib

object_name: HER2 positive breast carcinoma


subject: UNII:OS7097575K

object_name: triple-negative breast carcinoma


subject: UNII:OS7097575K

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:OS7097575K

object_name: breast neoplasm


subject: GTOPDB:13796

subject_name: serplulimab

object_name: Mismatch Repair Protein Proficient


subject: GTOPDB:13796

object_name: Marinesco-Sjogren syndrome


subject: GTOPDB:13796

object_name: Microsatellite Stable


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C4745029


subject: UMLS:C4745029


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:22652

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922

object_name: perinatal asphyxia


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: UMLS:C3254859

subject_name: sea buckthorn preparation

object_name: dry eye syndrome


subject: UMLS:C3541397

subject_name: oil ingredients


subject: MESH:D009821

subject_name: Oils


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEBI:95089

object_name: head and neck squamous cell carcinoma


subject: CHEBI:95089

object_name: Squamous cell carcinoma of head and neck recurrent


subject: CHEBI:95089

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: CHEBI:95089

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:95089

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:95089

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:95089

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:95089

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:95089

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:95089

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:95089

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:95089

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Castration-Sensitive Prostate Carcinoma


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Psychotic disorder due to a general medical condition


subject: UMLS:C0358855

object_name: Addiction


subject: UMLS:C0358855

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0358855

object_name: obesity


subject: UMLS:C0358855

object_name: Obesity, CTCAE


subject: CHEBI:32599

object_name: Perinatal anoxic-ischemic brain injury


subject: UNII:XQ43H3V6M1

subject_name: Subasumstat

object_name: Neck Carcinoma


subject: UNII:XQ43H3V6M1

object_name: head and neck neoplasm


subject: UNII:XQ43H3V6M1

object_name: head and neck cancer


subject: MESH:C000730454


subject: MESH:C000730454


subject: MESH:C000730454


subject: CHEBI:52970

object_name: Huntington disease


subject: CHEBI:60899


subject: CHEBI:177490


subject: CHEBI:167578


subject: CHEBI:64183

subject_name: Ubiquinol


subject: CHEBI:8499

subject_name: Propranolol

object_name: Peptic Ulcer


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]

object_name: liver cirrhosis


subject: UMLS:C3536754


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel

object_name: acute lymphoblastic leukemia


subject: DRUGBANK:DB16582

object_name: large B-cell lymphoma


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:31980

subject_name: Perflutren

object_name: peripheral vascular disease


subject: CHEBI:31980

object_name: peripheral arterial disease


subject: CHEBI:31980

object_name: Vasodilation disorder


subject: CHEBI:31980

object_name: intermittent vascular claudication


subject: CHEBI:33699

subject_name: messenger RNA

object_name: uveal melanoma


subject: UMLS:C4287707

subject_name: Cdk4/6 inhibitor shr6390

object_name: childhood neoplasm


subject: UMLS:C4287707

object_name: neoplastic syndrome


subject: UMLS:C4287707

object_name: cancer or benign tumor


subject: UMLS:C4287707

object_name: neoplasm


subject: CHEBI:183809

object_name: Alzheimer disease


subject: UMLS:C5907998

subject_name: STING Agonist BI 1703880

object_name: Solid Neoplasm


subject: UNII:5V1UI86573

subject_name: EZABENLIMAB


subject: UMLS:C4329334

subject_name: Ezabenlimab


subject: UMLS:C3537142

subject_name: Antiarrhythmic [EPC]

object_name: atrial fibrillation


subject: UMLS:C3537142

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C3537142

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5417856

subject_name: Cationic Peptide Cream Cypep-1

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C5417856

object_name: Advanced breast cancer


subject: UMLS:C5417856

object_name: Advanced Melanoma


subject: CHEBI:42446

subject_name: Esflurbiprofen

object_name: periodontitis


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: CHEBI:50634

object_name: high altitude headache


subject: CHEBI:27690

subject_name: Acetazolamide


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Anemia in chronic kidney disease


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:93NS566KF7

subject_name: GEMTUZUMAB

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0872968

subject_name: gemtuzumab


subject: PUBCHEM.COMPOUND:78122784

subject_name: Tenapanor

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:78122784

object_name: Chronic uremia


subject: CHEBI:33942

subject_name: ribose

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:33942

object_name: Fatigue


subject: CHEBI:47013

subject_name: D-ribofuranose


subject: CHEBI:47013


subject: CHEBI:16988

subject_name: D-ribose


subject: CHEBI:16988


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: polymyalgia rheumatica


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: extranodal nasal NK/T cell lymphoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:44915

subject_name: Propofol

object_name: Neuromuscular block, function


subject: CHEBI:8802

subject_name: Remifentanil


subject: UMLS:C5666978

subject_name: Anti-TIGIT Monoclonal Antibody BAT6021

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Depressed mood


subject: CHEBI:50733

object_name: Anhedonia


subject: CHEBI:8081

subject_name: Phentolamine

object_name: Menopause present (finding)


subject: CHEBI:8081

object_name: Menopause


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:135720

subject_name: Deflazacort

object_name: Hepatic impairment


subject: UMLS:C0873137

subject_name: Korean ginseng preparation

object_name: amnesia


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: UMLS:C5444072

subject_name: Panax ginseng allergen


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba


subject: UMLS:C3531686

subject_name: Ginkgo biloba whole extract


subject: UMLS:C0301532

subject_name: Multivitamin preparation


subject: UMLS:C0699320

subject_name: Endoxan

object_name: triple-negative breast carcinoma


subject: UMLS:C0699320

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5907896

subject_name: MIN 102

object_name: Cerebral Adrenoleukodystrophy


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution

object_name: Restless legs


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Parenteral nutrition-related hepatitis


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib

object_name: Solid Neoplasm


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: cutaneous squamous cell carcinoma


subject: CHEBI:85994

object_name: Neck Carcinoma


subject: CHEBI:85994

object_name: head and neck neoplasm


subject: CHEBI:85994

object_name: head and neck cancer


subject: CHEBI:47426

subject_name: Furosemide

object_name: Prostate cancer recurrent


subject: CHEBI:47426

object_name: prostate adenocarcinoma


subject: CHEBI:75929

object_name: panic disorder


subject: CHEBI:75929

object_name: panic disorder 1


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:40009


subject: UNII:413EU9081Y

subject_name: FIDANACOGENE ELAPARVOVEC

object_name: hemophilia B


subject: UNII:413EU9081Y

object_name: hemophilia B leyden


subject: CHEBI:17858

subject_name: oxiglutatione

object_name: kidney disorder


subject: CHEBI:17858

object_name: Increased reactive oxygen species production


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)


subject: CHEBI:177535


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate


subject: CHEBI:177258


subject: CHEBI:16856

subject_name: Glutathione


subject: CHEBI:16856


subject: CHEBI:3175

subject_name: Brimonidine

object_name: Subconjunctival hemorrhage


subject: CHEBI:3175

object_name: reported history of cataract surgery


subject: UMLS:C0520138

subject_name: INJECTION, CLONIDINE HYDROCHLORIDE, 1 MG ADMINISTERED

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C0520138


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: ST-elevation myocardial infarction


subject: UMLS:C0013227

object_name: ST Elevation Myocardial Infarction


subject: UMLS:C0013227

object_name: acute myocardial infarction


subject: UMLS:C0013227

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: testicular germ cell tumor 1


subject: CHEBI:175901

object_name: testicular germ cell tumor


subject: CHEBI:175901

object_name: childhood testicular germ cell tumor


subject: CHEBI:175901

object_name: extragonadal germ cell tumor


subject: UNII:6WS4C399GB

subject_name: Lenograstim


subject: UNII:6WS4C399GB


subject: UNII:6WS4C399GB


subject: UNII:6WS4C399GB


subject: UNII:6WS4C399GB

object_name: ovarian cancer


subject: UNII:6WS4C399GB

object_name: ovarian neoplasm


subject: UNII:6WS4C399GB

object_name: ovarian carcinoma


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:140739

subject_name: Glu-Gly-Phe

object_name: graft versus host disease


subject: GTOPDB:4916

subject_name: EGF


subject: CHEBI:58029

subject_name: cysteaminium

object_name: Fatty Liver


subject: CHEBI:17141

subject_name: Cysteamine


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: mental disorder


subject: CHEBI:93274

object_name: psychiatric disorder


subject: CHEBI:7936

subject_name: Paroxetine

object_name: Compulsion


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: triple-negative breast carcinoma


subject: CHEBI:15698

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C2983756

subject_name: Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205

object_name: lymphoma


subject: UNII:D68OW5RS98

subject_name: VIDUTOLIMOD

object_name: melanoma


subject: MESH:C111486

subject_name: gluma desensitizer

object_name: dentin sensitivity


subject: CHEBI:7824

subject_name: Oxcarbazepine

object_name: conduct disorder


subject: UMLS:C2827704

subject_name: 2-Hydroxyflutamide Depot

object_name: prostate carcinoma


subject: UMLS:C2827704

object_name: prostate cancer


subject: CHEBI:94531

subject_name: belinostat

object_name: Adenocarcinoma, metastatic


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:8382

subject_name: Prednisone

object_name: uveitis


subject: CHEBI:8382

object_name: Uveitis, CTCAE


subject: CHEBI:145499

subject_name: Donepezil

object_name: supranuclear palsy, progressive, 1


subject: CHEBI:145499

object_name: progressive supranuclear palsy


subject: UNII:IJ34D6YPAO

subject_name: Polmacoxib

object_name: localized primary osteoarthritis of knee


subject: UNII:IJ34D6YPAO

object_name: localized primary osteoarthritis of hip


subject: PUBCHEM.COMPOUND:4125253

subject_name: Dextran

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:4125253

object_name: acute kidney failure


subject: CHEBI:52071

subject_name: dextran


subject: CHEBI:52071


subject: CHEMBL.COMPOUND:CHEMBL2109168

subject_name: DEXTRAN 40


subject: CHEMBL.COMPOUND:CHEMBL2109168


subject: UMLS:C4530095

subject_name: varicella zoster virus glycoprotein E, recombinant

object_name: Shingles, CTCAE


subject: CHEBI:22586

subject_name: antioxidant

object_name: Ischemic reperfusion injury


subject: UMLS:C0003402

subject_name: Antioxidants


subject: CHEBI:49023

subject_name: prostaglandin antagonist


subject: UMLS:C0033529

subject_name: Prostaglandin Antagonists


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UNII:B33561JJ61

subject_name: TELAGLENASTAT HYDROCHLORIDE

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:B33561JJ61

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: UNII:B33561JJ61

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UMLS:C5418246

subject_name: Telaglenastat Hydrochloride


subject: UMLS:C5418246


subject: UMLS:C5418246


subject: UNII:6D5766Q4OP

subject_name: Olipudase alfa

object_name: acid sphingomyelinase deficiency


subject: UNII:6D5766Q4OP

object_name: Niemann-Pick disease


subject: PUBCHEM.COMPOUND:571831

object_name: cancer


subject: PUBCHEM.COMPOUND:571831

object_name: neoplasm


subject: PUBCHEM.COMPOUND:571831

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:571831

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:571831

object_name: Childhood Rectal Carcinoma


subject: PUBCHEM.COMPOUND:571831

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:571831

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:571831

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:571831

object_name: sigmoid colon cancer


subject: PUBCHEM.COMPOUND:571831

object_name: rectosigmoid junction cancer


subject: PUBCHEM.COMPOUND:571831

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:571831

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:571831

object_name: Solid Neoplasm


subject: CHEBI:6121

subject_name: Ketamine

object_name: Hemorrhage


subject: UMLS:C2981843

object_name: cervical intraepithelial neoplasia


subject: UMLS:C2981843

object_name: dysplasia of cervix


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: carcinoma


subject: GTOPDB:7988

object_name: esophageal adenocarcinoma


subject: GTOPDB:7988

object_name: lung adenocarcinoma


subject: GTOPDB:7988

object_name: cervical adenocarcinoma


subject: GTOPDB:7988

object_name: adenocarcinoma


subject: GTOPDB:7988

object_name: bile duct adenocarcinoma


subject: GTOPDB:7988

object_name: gastric adenocarcinoma


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: CHEBI:52763

object_name: melanoma


subject: UNII:8K80YB5GMG

subject_name: Rilonacept

object_name: Muckle-Wells syndrome


subject: UNII:8K80YB5GMG

object_name: Schnitzler syndrome


subject: UMLS:C2343505

subject_name: Arcalyst


subject: UMLS:C2343505


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: stroke due to basilar artery occlusion


subject: UNII:37KZM6S21G

object_name: basilar artery occlusion


subject: UNII:37KZM6S21G

object_name: Brain Infarction, Posterior Circulation


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: UMLS:C3826973

subject_name: Nanosomal Docetaxel Lipid Suspension

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Analgesic effect


subject: CHEBI:30762

subject_name: salicylate

object_name: acne


subject: CHEBI:9008

subject_name: salicylurate


subject: CHEBI:16914

subject_name: Salicylic acid


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Fabry disease


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:3561

subject_name: Cetirizine


subject: CHEBI:41879


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:5050

subject_name: Fexofenadine


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:50730

subject_name: Montelukast


subject: UMLS:C1608615

object_name: EXCESS LMW-DNA


subject: UMLS:C2830141

object_name: head and neck squamous cell carcinoma


subject: CHEBI:94366

subject_name: itraconazole

object_name: inflammatory bowel disease


subject: UMLS:C5564565


subject: CHEBI:167638

subject_name: Labetalol

object_name: no feeling or sensation of skin


subject: CHEBI:167638

object_name: Sensory Loss


subject: CHEMBL.COMPOUND:CHEMBL2108113

subject_name: SESAME OIL

object_name: lichen planus, oral


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: laryngeal squamous cell carcinoma


subject: UNII:6QVL057INT

object_name: oral cavity squamous cell carcinoma


subject: UNII:6QVL057INT

object_name: hypopharynx squamous cell carcinoma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C0445115

subject_name: Normal saline

object_name: neuralgia


subject: UMLS:C0445115

object_name: Neuropathic pain


subject: UMLS:C1377705

subject_name: Preservative free ingredient


subject: UMLS:C1377705


subject: CHEBI:15365

subject_name: Aspirin

object_name: infertility


subject: UNII:9X33544ILS

object_name: stroke disorder


subject: UNII:9X33544ILS

object_name: cerebrovascular disorder


subject: UNII:11G3FV7PG7

subject_name: ZONAMPANEL


subject: UNII:11G3FV7PG7


subject: UMLS:C4726991

subject_name: Zonampanel


subject: UMLS:C4726991


subject: UNII:950O97NUPO

subject_name: Preladenant

object_name: drug-induced dyskinesia


subject: UNII:950O97NUPO

object_name: Parkinsonism


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:81579

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: carcinoma of esophagus


subject: CHEBI:90001

object_name: esophageal cancer


subject: CHEBI:90001

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:90001

object_name: neoplasm of esophagus


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:91090

subject_name: charcoal

object_name: type 2 diabetes mellitus


subject: CHEBI:27594

subject_name: Graphite


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: xerophthalmia


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908

object_name: dry eye syndrome


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: renal pelvis/ureter urothelial carcinoma


subject: UMLS:C1166209

subject_name: Viscum album preparation

object_name: Stomach cancer


subject: UMLS:C1166209

object_name: gastric cancer


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: heart disorder


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Fractured ankle


subject: CHEBI:46195

object_name: Ankle Fracture, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:5779

subject_name: Hydrocodone


subject: CHEBI:5779


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UMLS:C3661302

subject_name: Infanrix hexa

object_name: pertussis


subject: CHEBI:18216

object_name: colorectal cancer


subject: CHEBI:18216

object_name: colorectal carcinoma


subject: CHEBI:18216

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:18216

object_name: Chemotherapy induced neutropenia


subject: PUBCHEM.COMPOUND:20057296

subject_name: Ganglioside GM1 (18:1/16:0)


subject: PUBCHEM.COMPOUND:20057296


subject: PUBCHEM.COMPOUND:20057296


subject: PUBCHEM.COMPOUND:20057296


subject: PUBCHEM.COMPOUND:20057300


subject: PUBCHEM.COMPOUND:20057300


subject: PUBCHEM.COMPOUND:20057300


subject: PUBCHEM.COMPOUND:20057300


subject: CHEBI:177678

subject_name: Ganglioside GM1 (18:1/12:0)


subject: CHEBI:177678


subject: CHEBI:177678


subject: CHEBI:177678


subject: PUBCHEM.COMPOUND:20057297

subject_name: Sygen


subject: PUBCHEM.COMPOUND:20057297


subject: PUBCHEM.COMPOUND:20057297


subject: PUBCHEM.COMPOUND:20057297


subject: PUBCHEM.COMPOUND:20057299

subject_name: Ganglioside GM1 (18:1/22:0)


subject: PUBCHEM.COMPOUND:20057299


subject: PUBCHEM.COMPOUND:20057299


subject: PUBCHEM.COMPOUND:20057299


subject: PUBCHEM.COMPOUND:20057301


subject: PUBCHEM.COMPOUND:20057301


subject: PUBCHEM.COMPOUND:20057301


subject: PUBCHEM.COMPOUND:20057301


subject: CHEBI:177701

subject_name: Ganglioside GM1 (18:1/9Z-18:1)


subject: CHEBI:177701


subject: CHEBI:177701


subject: CHEBI:177701


subject: PUBCHEM.COMPOUND:20057303

subject_name: Ganglioside GM1 (d18:1/24:0)


subject: PUBCHEM.COMPOUND:20057303


subject: PUBCHEM.COMPOUND:20057303


subject: PUBCHEM.COMPOUND:20057303


subject: CHEBI:73110

subject_name: ganglioside GM1(1-)


subject: CHEBI:73110


subject: CHEBI:73110


subject: CHEBI:73110


subject: CHEBI:61048

subject_name: Ganglioside GM1


subject: CHEBI:61048


subject: CHEBI:61048


subject: CHEBI:61048


subject: PUBCHEM.COMPOUND:20057298

subject_name: Ganglioside GM1 (18:1/20:0)


subject: PUBCHEM.COMPOUND:20057298


subject: PUBCHEM.COMPOUND:20057298


subject: PUBCHEM.COMPOUND:20057298


subject: PUBCHEM.COMPOUND:22833613

subject_name: Ganglioside GM1 (d18:1/25:0)


subject: PUBCHEM.COMPOUND:22833613


subject: PUBCHEM.COMPOUND:22833613


subject: PUBCHEM.COMPOUND:22833613


subject: PUBCHEM.COMPOUND:20057302

subject_name: Ganglioside GM1 (d18:1/26:0)


subject: PUBCHEM.COMPOUND:20057302


subject: PUBCHEM.COMPOUND:20057302


subject: PUBCHEM.COMPOUND:20057302


subject: CHEBI:119915

subject_name: Fentanyl

object_name: cleft palate


subject: CHEBI:119915

object_name: isolated cleft palate


subject: CHEBI:119915

object_name: cleft palate on exam


subject: CHEBI:5790

subject_name: Hydromorphone


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:167309

subject_name: Methadone


subject: CHEBI:167309


subject: CHEBI:167309


subject: UNII:1PON08459R

subject_name: ajmaline

object_name: ventricular tachycardia


subject: UNII:1PON08459R

object_name: atrial fibrillation


subject: UNII:1PON08459R

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:1PON08459R

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:2073

subject_name: Aritmina


subject: PUBCHEM.COMPOUND:2073


subject: PUBCHEM.COMPOUND:2073


subject: PUBCHEM.COMPOUND:2073


subject: CHEBI:58567

subject_name: ajmalinium


subject: CHEBI:58567


subject: CHEBI:58567


subject: CHEBI:58567


subject: CHEBI:91951

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Steroid diabetes


subject: CHEBI:8378

object_name: diabetes mellitus


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:91418

subject_name: Foretinib

object_name: Breast cancer recurrent


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: Aicardi-Goutieres syndrome


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: CHEBI:173106

subject_name: ferroptocide


subject: CHEBI:31536

subject_name: Emtricitabine


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: FGFR2 Gene Rearrangement


subject: UNII:28X28X9OKV

object_name: FGFR2 Gene Mutation


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: intrahepatic cholangiocarcinoma


subject: UNII:Y6BX7BL23K


subject: UNII:Y6BX7BL23K


subject: UNII:1LI341K7NQ

subject_name: CANFOSFAMIDE HYDROCHLORIDE

object_name: lung cancer


subject: UNII:1LI341K7NQ

object_name: lung neoplasm


subject: UNII:1LI341K7NQ

object_name: lung carcinoma


subject: CHEBI:135883

subject_name: Canfosfamide


subject: CHEBI:135883


subject: CHEBI:135883


subject: UMLS:C1258106

subject_name: TLK 286


subject: UMLS:C1258106


subject: UMLS:C1258106


subject: MESH:C573352

subject_name: NUTRIOSE

object_name: Overweight


subject: MESH:C573352

object_name: abdominal obesity-metabolic syndrome


subject: MESH:C573352

object_name: metabolic syndrome X


subject: UNII:T6HE85WN0Q

subject_name: PEGULICIANINE

object_name: peripheral vascular disease


subject: UNII:T6HE85WN0Q

object_name: peripheral arterial disease


subject: UNII:T6HE85WN0Q

object_name: carotid artery disorder


subject: PR:000034030

subject_name: FMN reductase (NADH) RutF

object_name: Child Malnutrition


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: adrenal cortex carcinoma


subject: CHEBI:233362

object_name: adenoid cystic carcinoma


subject: CHEBI:233362

object_name: Recurrent Adenoid Cystic Carcinoma


subject: CHEBI:233362

object_name: Metastatic adenoid cystic carcinoma


subject: CHEBI:232592


subject: CHEBI:232592


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994


subject: PUBCHEM.COMPOUND:131952892

subject_name: Lutetium (177Lu) oxodotreotide

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:131952892

object_name: primitive neuroectodermal tumor


subject: PUBCHEM.COMPOUND:131952892

object_name: peripheral primitive neuroectodermal tumor


subject: PUBCHEM.COMPOUND:131952892

object_name: germ cell tumor


subject: PUBCHEM.COMPOUND:131952892

object_name: Neoplasms by Histologic Type


subject: PUBCHEM.COMPOUND:131952892

object_name: malignant endocrine neoplasm


subject: PUBCHEM.COMPOUND:131952892

object_name: endocrine gland neoplasm


subject: PUBCHEM.COMPOUND:131952892

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:131952892

object_name: endocrine system disorder


subject: PUBCHEM.COMPOUND:131952892

object_name: digestive system neoplasm


subject: PUBCHEM.COMPOUND:131952892

object_name: Neoplasm of the gastrointestinal tract


subject: PUBCHEM.COMPOUND:131952892

object_name: pancreas disorder


subject: PUBCHEM.COMPOUND:131952892

object_name: digestive system disorder


subject: PUBCHEM.COMPOUND:131952892

object_name: gastrointestinal disease


subject: PUBCHEM.COMPOUND:131952892

object_name: nervous system cancer


subject: PUBCHEM.COMPOUND:131952892

object_name: intestinal cancer


subject: PUBCHEM.COMPOUND:131952892

object_name: intestinal neoplasm


subject: PUBCHEM.COMPOUND:131952892

object_name: gastric neoplasm


subject: PUBCHEM.COMPOUND:131952892

object_name: intestinal disorder


subject: PUBCHEM.COMPOUND:131952892

object_name: cancer


subject: PUBCHEM.COMPOUND:131952892

object_name: neoplasm


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: primitive neuroectodermal tumor


subject: UNII:MRL3739G66

object_name: peripheral primitive neuroectodermal tumor


subject: UNII:MRL3739G66

object_name: germ cell tumor


subject: UNII:MRL3739G66

object_name: Neoplasms by Histologic Type


subject: UNII:MRL3739G66

object_name: malignant endocrine neoplasm


subject: UNII:MRL3739G66

object_name: endocrine gland neoplasm


subject: UNII:MRL3739G66

object_name: endocrine system disorder


subject: UNII:MRL3739G66

object_name: digestive system neoplasm


subject: UNII:MRL3739G66

object_name: Neoplasm of the gastrointestinal tract


subject: UNII:MRL3739G66

object_name: pancreas disorder


subject: UNII:MRL3739G66

object_name: digestive system disorder


subject: UNII:MRL3739G66

object_name: gastrointestinal disease


subject: UNII:MRL3739G66

object_name: nervous system cancer


subject: UNII:MRL3739G66

object_name: intestinal cancer


subject: UNII:MRL3739G66

object_name: intestinal neoplasm


subject: UNII:MRL3739G66

object_name: gastric neoplasm


subject: UNII:MRL3739G66

object_name: intestinal disorder


subject: UNII:MRL3739G66

object_name: cancer


subject: UNII:MRL3739G66

object_name: neoplasm


subject: UNII:N3858377KC

object_name: neuroendocrine neoplasm


subject: UNII:N3858377KC

object_name: primitive neuroectodermal tumor


subject: UNII:N3858377KC

object_name: peripheral primitive neuroectodermal tumor


subject: UNII:N3858377KC

object_name: germ cell tumor


subject: UNII:N3858377KC

object_name: Neoplasms by Histologic Type


subject: UNII:N3858377KC

object_name: malignant endocrine neoplasm


subject: UNII:N3858377KC

object_name: endocrine gland neoplasm


subject: UNII:N3858377KC

object_name: pancreatic neoplasm


subject: UNII:N3858377KC

object_name: endocrine system disorder


subject: UNII:N3858377KC

object_name: digestive system neoplasm


subject: UNII:N3858377KC

object_name: Neoplasm of the gastrointestinal tract


subject: UNII:N3858377KC

object_name: pancreas disorder


subject: UNII:N3858377KC

object_name: digestive system disorder


subject: UNII:N3858377KC

object_name: gastrointestinal disease


subject: UNII:N3858377KC

object_name: nervous system cancer


subject: UNII:N3858377KC

object_name: intestinal cancer


subject: UNII:N3858377KC

object_name: intestinal neoplasm


subject: UNII:N3858377KC

object_name: gastric neoplasm


subject: UNII:N3858377KC

object_name: intestinal disorder


subject: UNII:N3858377KC

object_name: cancer


subject: UNII:N3858377KC

object_name: neoplasm


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: lung neoplasm


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:36373

subject_name: vindesine


subject: CHEBI:100246

subject_name: Norfloxacin

object_name: Cirrhosis


subject: CHEBI:100246

object_name: liver cirrhosis


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Mantle cell lymphoma refractory


subject: CHEBI:68534

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:68534

object_name: Mantle cell lymphoma stage I


subject: CHEBI:68534

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:68534

object_name: Ann Arbor Stage II Mantle Cell Lymphoma


subject: CHEBI:68534

object_name: Mantle cell lymphoma stage III


subject: PUBCHEM.COMPOUND:6095520

object_name: Ovarian hyperstimulation


subject: PUBCHEM.COMPOUND:89465

subject_name: Glucal


subject: CHEBI:3309

subject_name: Calcium gluconate


subject: CHEBI:35020

subject_name: Tributyrin

object_name: MELAS syndrome


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: angioedema


subject: UMLS:C0910794


subject: CHEBI:32150

object_name: Calcific Uraemic Arteriolopathy


subject: CHEBI:132112


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: asymptomatic hyperuricemia


subject: CHEBI:85078

object_name: Hyperuricemia without signs of inflammatory arthritis and tophaceous disease


subject: CHEBI:31596

subject_name: Febuxostat


subject: CHEBI:31596


subject: UNII:12WJ62D047

subject_name: Verinurad


subject: UNII:12WJ62D047


subject: UMLS:C5239340

subject_name: Nanoparticle-based Manganese-containing Contrast Agent SN132D

object_name: endometriosis


subject: CHEBI:93109

subject_name: Semaxanib

object_name: malignant mesothelioma


subject: CHEBI:91083

subject_name: Romiplostim


subject: PR:000023014

subject_name: translation initiation factor IF-3

object_name: acute myeloid leukemia with t(8;21)(q22;q22) translocation


subject: PR:000023014

object_name: acute myeloid leukemia, t(16;16)(p13.1;q22)


subject: PR:000023014

object_name: C-kit gene mutation


subject: UniProtKB:P0A707

subject_name: IF3_ECOLI Translation initiation factor IF-3 (sprot)


subject: UniProtKB:P0A707


subject: UniProtKB:P0A707


subject: UNII:513P80B4YJ

subject_name: Avapritinib


subject: UNII:513P80B4YJ


subject: PUBCHEM.COMPOUND:6328211

subject_name: Alhydrogel

object_name: Malaria, antepartum


subject: UMLS:C0733770


subject: PUBCHEM.COMPOUND:56998


subject: UMLS:C4722543

subject_name: Toll-like Receptor 4 Agonist GLA-SE


subject: UMLS:C4722544

subject_name: Glucopyranosyl Lipid Adjuvant-Stable Emulsion


subject: UNII:03J11K103C

subject_name: ALGELDRATE


subject: CHEBI:7465

subject_name: Naltrexone

object_name: type 1 diabetes mellitus


subject: CHEBI:7465

object_name: Loss of hypoglycemic warning due to diabetes mellitus


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Acute Ischemic Stroke


subject: CHEBI:74705

object_name: Ischemic stroke


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Heberden node


subject: CHEBI:93775

object_name: osteoarthritis, hand


subject: CHEBI:93775

object_name: Erosive osteoarthrosis


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: GTOPDB:11470

subject_name: ensovibep


subject: UNII:PV6AA88RDU


subject: CHEBI:57694

object_name: Malignant neoplasm of female breast


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: triple-negative breast carcinoma


subject: CHEBI:4806

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:4806


subject: CHEBI:6801

subject_name: Metformin


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C3491332

object_name: asthma


subject: CHEBI:3638

subject_name: Chloroquine

object_name: influenza


subject: UNII:UCC4EQS7WL

subject_name: TEZACITABINE

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:60799

subject_name: Tezacitabine


subject: UMLS:C1330606

subject_name: Wellbutrin XL

object_name: orgasm disorder


subject: UMLS:C5667049

subject_name: Protein-engineered Interleukin-2 XTX202

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: aortic valve disorder


subject: CHEBI:41879

object_name: aortic valve disease 1


subject: CHEBI:41879

object_name: Aortic Valve Disease, CTCAE


subject: CHEBI:94534

subject_name: olanzapine

object_name: coronary artery disorder


subject: CHEBI:94534

object_name: coronary atherosclerosis


subject: CHEBI:94534


subject: CHEBI:94534


subject: CHEBI:94534


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: complication


subject: CHEBI:3215

object_name: Respiratory complication


subject: CHEBI:3215

object_name: Phrenic nerve lesion


subject: CHEBI:3215

object_name: diaphragma sellae meningioma


subject: CHEBI:174615

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:174615

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: T-cell lymphoma recurrent


subject: CHEBI:83766

subject_name: Olaparib

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:83766

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:83766

object_name: T-cell lymphoma refractory


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: GTOPDB:12347

subject_name: penpulimab

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: CHEBI:229778

object_name: alopecia


subject: CHEBI:229778

object_name: Alopecia, CTCAE


subject: UniProtKB:P0A6Z1

subject_name: HSCA_ECOLI Chaperone protein HscA (sprot)


subject: UniProtKB:P0A6Z1


subject: PR:000007702


subject: PR:000007702


subject: PR:000022925

subject_name: chaperone protein HscA


subject: PR:000022925


subject: MESH:C505143

subject_name: Boostrix

object_name: diphtheria


subject: PUBCHEM.COMPOUND:89855776

object_name: Metastatic Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:89855776

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C4684848

subject_name: Methionine Aminopeptidase 2 Inhibitor M8891


subject: UMLS:C4684848


subject: UMLS:C2981820

object_name: Adenocarcinoma of the prostate stage I


subject: UMLS:C2981820

object_name: Adenocarcinoma of the prostate stage II


subject: UMLS:C2981820

object_name: Adenocarcinoma of the prostate stage III


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Abdominal pain


subject: CHEBI:89324

object_name: Abdominal Pain, CTCAE


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:174615

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: CHEBI:174615

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: CHEBI:174615

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: myeloid leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: follicular lymphoma


subject: UMLS:C5700219

object_name: Hodgkin Disease


subject: UMLS:C5700219

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C5700219

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C5700219

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5700219

object_name: non-Hodgkin lymphoma


subject: UMLS:C5700219

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5700219

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C5700219

object_name: Treatment related acute myeloid leukaemia


subject: UMLS:C5700219


subject: UMLS:C5700219


subject: UMLS:C5700219

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C5700219


subject: UMLS:C5700219

object_name: plasma cell myeloma


subject: UMLS:C5700219

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C5700219

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C5700219

object_name: Refractory acute myeloid leukemia


subject: UMLS:C5700219


subject: UMLS:C5700219

object_name: myelofibrosis


subject: CHEBI:59527

object_name: Lynch syndrome


subject: CHEBI:59527

object_name: Hereditary Nonpolyposis Colorectal Cancer


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: PUBCHEM.COMPOUND:123315041

subject_name: VIBEGRON

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:123315041

object_name: obesity


subject: PUBCHEM.COMPOUND:123315041

object_name: Obesity, CTCAE


subject: UMLS:C5667041

subject_name: CK1 Alpha Degrader CC-91633

object_name: Myelodysplasia


subject: UMLS:C5667041

object_name: acute myeloid leukemia


subject: UMLS:C2976005

object_name: essential hypertension


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: glucose intolerance


subject: CHEBI:16347

object_name: Glucose Intolerance, CTCAE


subject: UMLS:C0591236

subject_name: Carnitor


subject: UMLS:C0591236


subject: UMLS:C5435254

object_name: Inflammation


subject: UMLS:C5435254

object_name: Rheumatism


subject: CHEBI:7459

subject_name: Naloxone

object_name: pain agnosia


subject: CHEBI:7459

object_name: Pain insensitivity


subject: CHEBI:534

subject_name: Docusate


subject: CHEBI:534


subject: UMLS:C4547969

subject_name: apatinib mesylate

object_name: triple-negative breast carcinoma


subject: UMLS:C4547969

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:2YAD6KT0NT

object_name: hepatitis C


subject: UNII:2YAD6KT0NT

object_name: chronic hepatitis C virus infection


subject: UMLS:C4721712

subject_name: LEP-ETU

object_name: Childhood Breast Carcinoma


subject: UMLS:C4721712

object_name: breast carcinoma


subject: UMLS:C4721712

object_name: breast cancer


subject: CHEBI:27374

subject_name: Levoinositol

object_name: acne


subject: CHEBI:27372


subject: GTOPDB:9596

subject_name: oleclumab


subject: UNII:5CRY01URYQ

subject_name: OLECLUMAB


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: aorta coarctation


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Vomiting, CTCAE


subject: CHEBI:60648

object_name: Vomiting


subject: CHEBI:60648

object_name: abortion


subject: CHEBI:60648

object_name: Induced Abortion Finding


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: UMLS:C2756587

subject_name: soy

object_name: fibromyalgia


subject: UMLS:C1697820

subject_name: soy - non-drug agent


subject: CHEBI:145751

subject_name: Asn-Arg

object_name: cystic fibrosis


subject: CHEBI:15927

subject_name: Nicotinamide riboside


subject: CHEBI:84040


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:7627

subject_name: Norethisterone

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:7627

object_name: Dysmenorrhea


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: adult acute myeloid leukemia


subject: CHEBI:135918

object_name: Neoplasm, Residual


subject: UNII:G1G66XE93W

object_name: lung adenocarcinoma


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Abortion induced complicated


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate

object_name: meningeal tuberculosis


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: CHEBI:167309

subject_name: Methadone

object_name: post operative nausea and vomiting


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: PUBCHEM.COMPOUND:135436482

subject_name: Calcium folinate


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:82339

subject_name: Merphalan

object_name: unilateral retinoblastoma


subject: CHEBI:28876

subject_name: Melphalan


subject: UNII:XX2BGT8CLL

subject_name: BRIVEKIMIG

object_name: focal segmental glomerulosclerosis


subject: UNII:XX2BGT8CLL

object_name: lipoid nephrosis


subject: UMLS:C5960042

subject_name: Brivekimig


subject: UMLS:C5960042


subject: CHEMBL.COMPOUND:CHEMBL5095122

subject_name: FREXALIMAB


subject: CHEMBL.COMPOUND:CHEMBL5095122


subject: UMLS:C5787323

subject_name: Frexalimab


subject: UMLS:C5787323


subject: UNII:5G1WE425BI

subject_name: Rilzabrutinib


subject: UNII:5G1WE425BI


subject: UNII:NWN58M4F5T

subject_name: RILZABRUTINIB


subject: UNII:NWN58M4F5T


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: cardiovascular disorder


subject: UMLS:C0971731


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: Aggressive behavior


subject: UNII:2N4O9L084N

object_name: Aggression


subject: UNII:2N4O9L084N

object_name: intellectual disability


subject: UNII:2N4O9L084N

object_name: developmental disability


subject: UNII:2N4O9L084N

object_name: Atypical behavior


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: bipolar disorder


subject: GTOPDB:8451

subject_name: demcizumab

object_name: pancreatic neoplasm


subject: GTOPDB:8451

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:8451

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109384

subject_name: DEMCIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109384


subject: CHEMBL.COMPOUND:CHEMBL2109384


subject: UMLS:C2698134


subject: UMLS:C2698134


subject: UMLS:C2698134


subject: UMLS:C2976213

object_name: prostate carcinoma


subject: UMLS:C2976213

object_name: prostate cancer


subject: UNII:I7T908772F

subject_name: alum

object_name: dengue disease


subject: UNII:03J11K103C

subject_name: ALGELDRATE


subject: CHEBI:16899

subject_name: Mannitol

object_name: Complication of hemodialysis


subject: CHEBI:16899

object_name: Hemodynamic instability


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Maternity blues


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Depressed mood


subject: UNII:1C6V77QF41

object_name: Cancer patients and suicide and depression


subject: UNII:1C6V77QF41

object_name: Depressed - symptom


subject: UNII:1C6V77QF41

object_name: Depression, CTCAE


subject: UNII:1C6V77QF41


subject: CHEBI:8871

subject_name: Risperidone

object_name: Major depression with psychotic features


subject: UNII:9078K3MO9U

subject_name: copper bis(histidinate)

object_name: Menkes disease


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Burn of periorbital region


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:35341

subject_name: steroid


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: PUBCHEM.COMPOUND:46874763


subject: UMLS:C0003232

subject_name: Antibiotics


subject: PUBCHEM.COMPOUND:56841899

subject_name: Maxitrol


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C0526091


subject: CHEBI:137064

subject_name: Galunisertib

object_name: ovarian carcinosarcoma


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: aortic valve disease 1


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Incipient Schizophrenia


subject: CHEBI:49575

subject_name: Diazepam


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: non-Hodgkin lymphoma


subject: HMDB:HMDB0013470

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: HMDB:HMDB0013470

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: HMDB:HMDB0013470

object_name: acute myeloid leukemia


subject: HMDB:HMDB0013470

object_name: acute lymphoblastic leukemia


subject: HMDB:HMDB0013470

object_name: Myelodysplasia


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEBI:89981


subject: GTOPDB:4996


subject: GTOPDB:4996


subject: GTOPDB:4996


subject: GTOPDB:4996


subject: GTOPDB:4996


subject: GTOPDB:4996


subject: PR:000001391


subject: PR:000001391


subject: PR:000001391


subject: PR:000001391


subject: PR:000001391


subject: PR:000001391


subject: UMLS:C1522540

subject_name: Recombinant Interleukin-4


subject: UMLS:C1522540


subject: UMLS:C1522540


subject: UMLS:C1522540


subject: UMLS:C1522540


subject: UMLS:C1522540


subject: UMLS:C3486572

subject_name: binetrakin


subject: UMLS:C3486572


subject: UMLS:C3486572


subject: UMLS:C3486572


subject: UMLS:C3486572


subject: UMLS:C3486572


subject: UMLS:C0064332

subject_name: keyhole-limpet hemocyanin


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C4745461

subject_name: ABP 450

object_name: Wrinkled structure


subject: UMLS:C4745461

object_name: Skin Wrinkling


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Heart Failure, CTCAE


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: UNII:18AP231HUP

subject_name: TEGAVIVINT

object_name: Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: UNII:18AP231HUP

object_name: Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: UNII:18AP231HUP

object_name: Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: UNII:18AP231HUP

object_name: Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: UNII:18AP231HUP

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:18AP231HUP

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:18AP231HUP

object_name: Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:18AP231HUP

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:18AP231HUP

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: DRUGBANK:DB17109

subject_name: Tegavivint


subject: DRUGBANK:DB17109


subject: DRUGBANK:DB17109